1.Male/females of â?¥ 18 years of age at the time of consent <br/ >2.Patient who can and willing to provide written Informed Consent <br/ >3 Moderate Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test /any other confirmatory tests <br/ >4 Patient with pneumonia with no signs of severe disease <br/ >5 If the patient presents any one of the following features: <br/ >-Respiratory rate of â?¥â??24 breath/min <br/ >-SpO2 (oxygen saturation) â?¤â??94% on room air <br/ >6.Patient/ patientâ??s LAR understands and is willing to participate in the clinical study and can comply with clinical trial protocol requirements <br/ >

1.Male/females of â?¥ 18 years of age at the time of consent <br/ >2.Patient who can and willing to provide written Informed Consent <br/ >3 Moderate Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test /any other confirmatory tests <br/ >4 Patient with pneumonia with no signs of severe disease <br/ >5 If the patient presents any one of the following features: <br/ >-Respiratory rate of â?¥â??24 breath/min <br/ >-SpO2 (oxygen saturation) â?¤â??94% on room air <br/ >6.Patient/ patientâ??s LAR understands and is willing to participate in the clinical study and can comply with clinical trial protocol requirements <br/ >

1.Male/females of â?¥ 18 years of age at the time of consent <br/ >2.Patient who can and willing to provide written Informed Consent <br/ >3 Moderate Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test /any other confirmatory tests <br/ >4 Patient with pneumonia with no signs of severe disease <br/ >5 If the patient presents any one of the following features: <br/ >-Respiratory rate of â?¥â??24 breath/min <br/ >-SpO2 (oxygen saturation) â?¤â??94% on room air <br/ >6.Patient/ patientâ??s LAR understands and is willing to participate in the clinical study and can comply with clinical trial protocol requirements <br/ >

1.Male/females of â?¥ 18 years of age at the time of consent <br/ >2.Patient who can and willing to provide written Informed Consent <br/ >3 Moderate Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2 infection confirmed by polymerase chain reaction (PCR) test /any other confirmatory tests <br/ >4 Patient with pneumonia with no signs of severe disease <br/ >5 If the patient presents any one of the following features: <br/ >-Respiratory rate of â?¥â??24 breath/min <br/ >-SpO2 (oxygen saturation) â?¤â??94% on room air <br/ >6.Patient/ patientâ??s LAR understands and is willing to participate in the clinical study and can comply with clinical trial protocol requirements <br/ >